These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 30733667)

  • 1. Specific Expression of a New Bruton Tyrosine Kinase Isoform (p65BTK) in the Glioblastoma Gemistocytic Histotype.
    Sala L; Cirillo G; Riva G; Romano G; Giussani C; Cialdella A; Todisco A; Virtuoso A; Cerrito MG; Bentivegna A; Grassilli E; Ardizzoia A; Bonoldi E; Giovannoni R; Papa M; Lavitrano M
    Front Mol Neurosci; 2019; 12():2. PubMed ID: 30733667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p65BTK Is a Novel Biomarker and Therapeutic Target in Solid Tumors.
    Grassilli E; Cerrito MG; Bonomo S; Giovannoni R; Conconi D; Lavitrano M
    Front Cell Dev Biol; 2021; 9():690365. PubMed ID: 34164404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p65BTK is a novel potential actionable target in KRAS-mutated/EGFR-wild type lung adenocarcinoma.
    Giordano F; Vaira V; Cortinovis D; Bonomo S; Goedmakers J; Brena F; Cialdella A; Ianzano L; Forno I; Cerrito MG; Giovannoni R; Ferri GL; Tasciotti E; Vicent S; Damarco F; Bosari S; Lavitrano M; Grassilli E
    J Exp Clin Cancer Res; 2019 Jun; 38(1):260. PubMed ID: 31200752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Bruton's Tyrosine Kinase in Stage III Colorectal Cancer.
    Basile D; Gerratana L; Buonadonna A; Garattini SK; Perin T; Grassilli E; Miolo G; Cerrito MG; Belluco C; Bertola G; De Paoli A; Cannizzaro R; Lavitrano M; Puglisi F; Canzonieri V
    Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31238520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BTK inhibitors synergise with 5-FU to treat drug-resistant TP53-null colon cancers.
    Lavitrano M; Ianzano L; Bonomo S; Cialdella A; Cerrito MG; Pisano F; Missaglia C; Giovannoni R; Romano G; McLean CM; Voest EE; D'Amato F; Noli B; Ferri GL; Agostini M; Pucciarelli S; Helin K; Leone BE; Canzonieri V; Grassilli E
    J Pathol; 2020 Feb; 250(2):134-147. PubMed ID: 31518438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformation.
    Grassilli E; Pisano F; Cialdella A; Bonomo S; Missaglia C; Cerrito MG; Masiero L; Ianzano L; Giordano F; Cicirelli V; Narloch R; D'Amato F; Noli B; Ferri GL; Leone BE; Stanta G; Bonin S; Helin K; Giovannoni R; Lavitrano M
    Oncogene; 2016 Aug; 35(33):4368-78. PubMed ID: 26804170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Bruton's tyrosine kinase in B cells and malignancies.
    Pal Singh S; Dammeijer F; Hendriks RW
    Mol Cancer; 2018 Feb; 17(1):57. PubMed ID: 29455639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferation of gemistocytic cells and glial fibrillary acidic protein (GFAP)-positive oligodendroglial cells in gliomas: a MIB-1/GFAP double labeling study.
    Kros JM; Schouten WC; Janssen PJ; van der Kwast TH
    Acta Neuropathol; 1996; 91(1):99-103. PubMed ID: 8773153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology.
    Babu R; Bagley JH; Park JG; Friedman AH; Adamson C
    J Neurosurg; 2013 Aug; 119(2):434-41. PubMed ID: 23662821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atracurium Besylate and other neuromuscular blocking agents promote astroglial differentiation and deplete glioblastoma stem cells.
    Spina R; Voss DM; Asnaghi L; Sloan A; Bar EE
    Oncotarget; 2016 Jan; 7(1):459-72. PubMed ID: 26575950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SLUG and Truncated TAL1 Reduce Glioblastoma Stem Cell Growth Downstream of Notch1 and Define Distinct Vascular Subpopulations in Glioblastoma Multiforme.
    Guelfi S; Orsetti B; Deleuze V; Rigau V; Bauchet L; Duffau H; Rothhut B; Hugnot JP
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaplastic human gliomas grown in athymic mice. Morphology and glial fibrillary acidic protein expression.
    Jones TR; Bigner SH; Schold SC; Eng LF; Bigner DD
    Am J Pathol; 1981 Dec; 105(3):316-27. PubMed ID: 6274201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mTOR kinase inhibitor everolimus synergistically enhances the anti-tumor effect of the Bruton's tyrosine kinase (BTK) inhibitor PLS-123 on Mantle cell lymphoma.
    Li J; Wang X; Xie Y; Ying Z; Liu W; Ping L; Zhang C; Pan Z; Ding N; Song Y; Zhu J
    Int J Cancer; 2018 Jan; 142(1):202-213. PubMed ID: 28905990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-clinical anti-tumor activity of Bruton's Tyrosine Kinase inhibitor in Hodgkin's Lymphoma cellular and subcutaneous tumor model.
    Muqbil I; Chaker M; Aboukameel A; Mohammad RM; Azmi AS; Ramchandren R
    Heliyon; 2019 Aug; 5(8):e02290. PubMed ID: 31508518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PI3Kδ inhibitor idelalisib in combination with BTK inhibitor ONO/GS-4059 in diffuse large B cell lymphoma with acquired resistance to PI3Kδ and BTK inhibitors.
    Yahiaoui A; Meadows SA; Sorensen RA; Cui ZH; Keegan KS; Brockett R; Chen G; Quéva C; Li L; Tannheimer SL
    PLoS One; 2017; 12(2):e0171221. PubMed ID: 28178345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the epidermal growth factor receptor in human gliomas: II. The control of glial process extension and the expression of glial fibrillary acidic protein.
    Hoi Sang U; Espiritu OD; Kelley PY; Klauber MR; Hatton JD
    J Neurosurg; 1995 May; 82(5):847-57. PubMed ID: 7714612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytogenetic analysis of gemistocytic cells in gliomas.
    Kros JM; Waarsenburg N; Hayes DP; Hop WC; van Dekken H
    J Neuropathol Exp Neurol; 2000 Aug; 59(8):679-86. PubMed ID: 10952058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G-protein coupled receptor kinase (GRK)-5 regulates proliferation of glioblastoma-derived stem cells.
    Kaur G; Kim J; Kaur R; Tan I; Bloch O; Sun MZ; Safaee M; Oh MC; Sughrue M; Phillips J; Parsa AT
    J Clin Neurosci; 2013 Jul; 20(7):1014-8. PubMed ID: 23693024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of GFAP and EGFR in primary and recurrent high-grade gliomas: correlation to tumor volume, molecular markers, and progression-free survival.
    Kiviniemi A; Gardberg M; Frantzén J; Parkkola R; Vuorinen V; Pesola M; Minn H
    J Neurooncol; 2015 Sep; 124(2):237-45. PubMed ID: 26033547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.